|
CN105218560A
|
|
The synthesis technique of 7-bromo-4-diuril phenol also [3,2-D] pyrimidine
|
|
CN105218405A
|
|
The synthesis technique of (R, S)-2-[[5-(9-fluorenylmethyloxycarbonyl is amino) dibenzo [A, D] suberane-2-base] oxygen] acetic acid
|
|
CN105330612A
|
|
Synthesis process of 2-(5-amino-1,2,4-thiadiazol-3-yl)-2-(methoxyimino)acetic acid
|
|
CN105218554A
|
|
The synthesis technique of 4-chlorine pyrrolo-[2,3-D] pyrimidine
|
|
CN105218546A
|
|
The synthesis technique of 1H-pyrrolo-[2,3-B] pyridine-3-carboxylic acid methyl esters
|
|
CN105198813A
|
|
Synthesizing process of 3-methyl-1 H-indazole
|
|
CN105198819A
|
|
Synthesizing process of benzimidazole-2-formaldehyde
|
|
CN105198833A
|
|
Synthesizing process of benzothiazole-2-formaldehyde
|
|
CN105198834A
|
|
Synthesizing process of 2, 6-dibromo benzothiazole
|
|
CN105198835A
|
|
Synthesizing process of benzothiazole-2-formic acid
|
|
CN105198881A
|
|
Synthesizing process of 5-bromo-3-methyl-1H-pyrazolo [3, 4-B] pyridine
|
|
CN105198887A
|
|
Synthetic process of novel pyrazol [3,4-d] miazines reagent with biological activity
|
|
CN104830765A
|
|
High efficiency fetal calf serum substitute
|
|
CN104830902A
|
|
Preparation method and application of monoclonal antibody
|
|
CN104845966A
|
|
Novel bacterial RNA (ribonucleic acid) extraction reagent and preparing method thereof
|
|
CN104830890A
|
|
High yielding cellulase engineering bacterium and application thereof
|
|
CN104447696A
|
|
Synthetic process of lansoprazole
|
|
CN104478909A
|
|
Synthetic process of heterocyclic boric acid compound
|
|
CN104447517A
|
|
Synthetic process of high-purity fluorinated reagent for developing novel anti-cancer drugs
|
|
CN104478977A
|
|
Process for synthesizing purine compounds
|
